Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript

ENDOCYTE INC (ECYT) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/21/2018 4 MIDDLETON FRED A (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 83,860 shares @ $0
Disposed/sold 110,189 shares @ $24, valued at $2.6M
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 1,017,304 shares @ $24, valued at $24.4M
Disposed/sold 1,212,413 shares @ $24, valued at $29.1M
Disposed/sold 267,491 shares @ $24, valued at $6.4M
Disposed/sold 249,148 shares @ $24, valued at $6M
Disposed/sold 162,170 shares @ $24, valued at $3.9M
Disposed/sold 113,315 shares @ $24, valued at $2.7M
Disposed/sold 100,828 shares @ $24, valued at $2.4M
Disposed/sold 10,049 shares @ $24, valued at $241.2k
12/21/2018 4 Machado Patrick (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 1,250 shares @ $24, valued at $30k
Disposed/sold 2,500 shares @ $24, valued at $60k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 22,500 options to buy @ $4.2, valued at $94.5k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 McAvoy David R. (General Counsel) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 2,119 shares @ $24, valued at $50.9k
Disposed/sold 23,750 shares @ $24, valued at $570k
Disposed/sold 37,500 options to buy @ $2.96, valued at $111k
12/21/2018 4 Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 164,256 shares @ $24, valued at $3.9M
Disposed/sold 4,375 shares @ $24, valued at $105k
Disposed/sold 13,125 shares @ $24, valued at $315k
Disposed/sold 20,000 shares @ $24, valued at $480k
Disposed/sold 22,500 shares @ $24, valued at $540k
Disposed/sold 27,500 options to buy @ $9.05, valued at $248.9k
Disposed/sold 59,996 options to buy @ $3.55, valued at $213k
Disposed/sold 70,000 options to buy @ $9.86, valued at $690.2k
Disposed/sold 45,000 options to buy @ $11.11, valued at $500k
Disposed/sold 52,498 options to buy @ $5.1, valued at $267.7k
Disposed/sold 52,498 options to buy @ $3.18, valued at $166.9k
12/21/2018 4 Armour Alison A. (Chief Medical Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 10,500 shares @ $0
Gifted 10,500 shares @ $0
Disposed/sold 72,253 shares @ $24, valued at $1.7M
Disposed/sold 10,500 shares @ $24, valued at $252k
Disposed/sold 5,000 shares @ $24, valued at $120k
Disposed/sold 15,000 shares @ $24, valued at $360k
Disposed/sold 20,000 shares @ $24, valued at $480k
Disposed/sold 22,500 shares @ $24, valued at $540k
Disposed/sold 25,000 options to buy @ $5.16, valued at $129k
Disposed/sold 45,788 options to buy @ $3.18, valued at $145.6k
Disposed/sold 39,999 options to buy @ $2.16, valued at $86.4k
12/21/2018 4 Parker Katherine (VP of Human Resources) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 8,229 shares @ $0
Disposed/sold 22,797 shares @ $24, valued at $547.1k
Disposed/sold 3,125 shares @ $24, valued at $75k
Disposed/sold 9,375 shares @ $24, valued at $225k
Disposed/sold 15,000 shares @ $24, valued at $360k
Disposed/sold 12,500 shares @ $24, valued at $300k
Disposed/sold 1,200 shares @ $24, valued at $28.8k
Disposed/sold 19,000 options to buy @ $11.47, valued at $217.9k
Disposed/sold 60,000 options to buy @ $5.1, valued at $306k
Disposed/sold 37,500 options to buy @ $3.18, valued at $119.3k
Disposed/sold 25,000 options to buy @ $2.16, valued at $54k
12/21/2018 4 Russell Lesley (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 7,800 shares @ $24, valued at $187.2k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 28,000 options to buy @ $9.63, valued at $269.6k
Disposed/sold 14,000 options to buy @ $12.94, valued at $181.2k
Disposed/sold 14,000 options to buy @ $6.69, valued at $93.7k
Disposed/sold 13,500 options to buy @ $6.02, valued at $81.3k
Disposed/sold 13,500 options to buy @ $3.35, valued at $45.2k
Disposed/sold 19,500 options to buy @ $2.27, valued at $44.3k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 Chelius Erik C. (Vice President CMC) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 15,848 shares @ $24, valued at $380.4k
Disposed/sold 3,516 shares @ $24, valued at $84.4k
Disposed/sold 4,281 shares @ $24, valued at $102.7k
Disposed/sold 10,000 shares @ $24, valued at $240k
Disposed/sold 16,250 shares @ $24, valued at $390k
Disposed/sold 14,000 options to buy @ $3.64, valued at $51k
Disposed/sold 15,500 options to buy @ $9.86, valued at $152.8k
Disposed/sold 10,850 options to buy @ $11.11, valued at $120.5k
Disposed/sold 11,568 options to buy @ $5.1, valued at $59k
Disposed/sold 14,062 options to buy @ $3.18, valued at $44.7k
Disposed/sold 11,413 options to buy @ $2.16, valued at $24.7k
12/21/2018 4 APLIN JOHN C (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 28,863 shares @ $24, valued at $692.7k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 15,706 options to buy @ $6, valued at $94.2k
Disposed/sold 10,000 options to buy @ $11.8, valued at $118k
Disposed/sold 10,000 options to buy @ $6.43, valued at $64.3k
Disposed/sold 14,000 options to buy @ $12.94, valued at $181.2k
Disposed/sold 14,000 options to buy @ $6.69, valued at $93.7k
Disposed/sold 13,500 options to buy @ $6.02, valued at $81.3k
Disposed/sold 13,500 options to buy @ $3.35, valued at $45.2k
Disposed/sold 19,500 options to buy @ $2.27, valued at $44.3k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 Taylor Beth (VP Finance & Chief Acctg Off) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 59,509 shares @ $24, valued at $1.4M
Disposed/sold 1,250 shares @ $24, valued at $30k
Disposed/sold 1,875 shares @ $24, valued at $45k
Disposed/sold 7,500 shares @ $24, valued at $180k
Disposed/sold 15,000 shares @ $24, valued at $360k
Disposed/sold 12,500 shares @ $24, valued at $300k
Disposed/sold 23,560 options to buy @ $7.41, valued at $174.6k
Disposed/sold 9,132 options to buy @ $9.86, valued at $90k
Disposed/sold 10,850 options to buy @ $11.11, valued at $120.5k
Disposed/sold 3,750 options to buy @ $3.18, valued at $11.9k
Disposed/sold 12,969 options to buy @ $3.21, valued at $41.6k
12/21/2018 4 GODDARD COLIN (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 7,800 shares @ $24, valued at $187.2k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 28,000 options to buy @ $10.37, valued at $290.4k
Disposed/sold 14,000 options to buy @ $6.69, valued at $93.7k
Disposed/sold 13,500 options to buy @ $6.02, valued at $81.3k
Disposed/sold 13,500 options to buy @ $3.35, valued at $45.2k
Disposed/sold 19,500 options to buy @ $2.27, valued at $44.3k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 Svoronos Dawn (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 3,750 shares @ $24, valued at $90k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 22,500 options to buy @ $10.81, valued at $243.2k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 KOZIN MARC D (Director) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 7,800 shares @ $24, valued at $187.2k
Disposed/sold 3,300 shares @ $24, valued at $79.2k
Disposed/sold 20,000 options to buy @ $7.71, valued at $154.2k
Disposed/sold 14,000 options to buy @ $12.94, valued at $181.2k
Disposed/sold 14,000 options to buy @ $6.69, valued at $93.7k
Disposed/sold 13,500 options to buy @ $6.02, valued at $81.3k
Disposed/sold 13,500 options to buy @ $3.35, valued at $45.2k
Disposed/sold 19,500 options to buy @ $2.27, valued at $44.3k
Disposed/sold 19,500 options to buy @ $10.81, valued at $210.8k
12/21/2018 4 Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 243,739 shares @ $24, valued at $5.8M
Disposed/sold 19,919 shares @ $24, valued at $478.1k
Disposed/sold 7,188 shares @ $24, valued at $172.5k
Disposed/sold 5,000 shares @ $24, valued at $120k
Disposed/sold 23,438 shares @ $24, valued at $562.5k
Disposed/sold 62,500 shares @ $24, valued at $1.5M
Disposed/sold 37,500 shares @ $24, valued at $900k
Disposed/sold 20,800 options to buy @ $9.05, valued at $188.2k
Disposed/sold 74,998 options to buy @ $3.55, valued at $266.2k
Disposed/sold 58,719 options to buy @ $9.86, valued at $579k
Disposed/sold 36,000 options to buy @ $11.11, valued at $400k
12/21/2018 4 Low Philip S (Chief Science Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 349,944 shares @ $24, valued at $8.4M
Disposed/sold 132,473 shares @ $24, valued at $3.2M
Disposed/sold 4,375 shares @ $24, valued at $105k
Disposed/sold 13,125 shares @ $24, valued at $315k
Disposed/sold 20,000 shares @ $24, valued at $480k
Disposed/sold 22,500 shares @ $24, valued at $540k
Disposed/sold 13,570 options to buy @ $3.82, valued at $51.8k
Disposed/sold 8,560 options to buy @ $9.05, valued at $77.5k
Disposed/sold 17,950 options to buy @ $11.8, valued at $211.8k
Disposed/sold 59,996 options to buy @ $3.55, valued at $213k
Disposed/sold 56,918 options to buy @ $9.86, valued at $561.2k
12/21/2018 4 Andriole Michael T. (CFO) has filed a Form 4 on ENDOCYTE INC
Txns: Disposed/sold 52,582 shares @ $24, valued at $1.3M
Disposed/sold 37,500 shares @ $24, valued at $900k
Disposed/sold 25,000 shares @ $24, valued at $600k
Disposed/sold 75,000 options to buy @ $2.22, valued at $166.5k
Disposed/sold 50,000 options to buy @ $3.01, valued at $150.5k
12/19/2018 4 Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 2,500 shares @ $0
Gifted 1,250 shares @ $0
Gifted 3,186 shares @ $0
Gifted 1,250 shares @ $0
Exercised 16,073 options to buy @ $3.55, valued at $57.1k
Exercised 5,500 options to buy @ $9.86, valued at $54.2k
Exercised 9,000 options to buy @ $5.1, valued at $45.9k
Exercised 3,750 options to buy @ $3.18, valued at $11.9k
Exercised 9,531 options to buy @ $3.21, valued at $30.6k
Exercised 5,000 options to buy @ $2.16, valued at $10.8k
12/19/2018 4 Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC
Txns: Exercised 20,000 options to buy @ $2.54, valued at $50.8k
Exercised 26,177 options to buy @ $3.82, valued at $100k
Exercised 13,089 options to buy @ $7.49, valued at $98k
Exercised 22,500 options to buy @ $9.05, valued at $203.6k
Exercised 20,004 options to buy @ $3.55, valued at $71k
Exercised 2 options to buy @ $5.1, valued at $10.2
Exercised 2 options to buy @ $3.18, valued at $6.4
12/19/2018 4 Andriole Michael T. (CFO) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 4,500 shares @ $0
Exercised 25,000 options to buy @ $2.22, valued at $55.5k
12/19/2018 4 Armour Alison A. (Chief Medical Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Exercised 35,000 options to buy @ $5.16, valued at $180.6k
Exercised 14,212 options to buy @ $3.18, valued at $45.2k
Exercised 1 options to buy @ $2.16, valued at $2.2
12/19/2018 4 Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 84,112 shares @ $0
Exercised 5,330 options to buy @ $2.54, valued at $13.5k
Exercised 10,035 options to buy @ $2.54, valued at $25.5k
Exercised 15,706 options to buy @ $3.82, valued at $60k
Exercised 39,200 options to buy @ $9.05, valued at $354.8k
Exercised 25,002 options to buy @ $3.55, valued at $88.8k
Exercised 11,281 options to buy @ $9.86, valued at $111.2k
Exercised 9,000 options to buy @ $11.11, valued at $100k
Exercised 3 options to buy @ $5.1, valued at $15.3
Exercised 2 options to buy @ $3.18, valued at $6.4
12/19/2018 4 Low Philip S (Chief Science Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 52,512 shares @ $0
Gifted 52,346 shares @ $0
Exercised 22,759 options to buy @ $2.54, valued at $57.8k
Exercised 51,875 options to buy @ $3.82, valued at $198.2k
Exercised 21,440 options to buy @ $9.05, valued at $194k
Exercised 2,050 options to buy @ $11.8, valued at $24.2k
Exercised 20,004 options to buy @ $3.55, valued at $71k
Exercised 13,082 options to buy @ $9.86, valued at $129k
Exercised 9,000 options to buy @ $11.11, valued at $100k
Exercised 2 options to buy @ $5.1, valued at $10.2
Exercised 2 options to buy @ $3.18, valued at $6.4
10/09/2018 4 Armour Alison A. (Chief Medical Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 9,111 shares @ $15.5579, valued at $141.7k
10/09/2018 4 Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 9,028 shares @ $15.5557, valued at $140.4k
10/09/2018 4 Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 7,022 shares @ $15.5635, valued at $109.3k
10/09/2018 4 Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 28,146 shares @ $15.5529, valued at $437.8k
10/09/2018 4 Andriole Michael T. (CFO) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 17,283 shares @ $15.5519, valued at $268.8k
Sold 635 shares @ $15.85, valued at $10.1k
10/09/2018 4 Chelius Erik C. (Vice President CMC) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 4,514 shares @ $15.5611, valued at $70.2k
10/09/2018 4 Parker Katherine (VP of Human Resources) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 6,771 shares @ $15.554, valued at $105.3k
10/09/2018 4 Low Philip S (Chief Science Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Gifted 294 shares @ $0
Sold 5,928 shares @ $15.5597, valued at $92.2k
08/29/2018 4 Leamon Christopher P (Vice President of Research) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 12,670 shares @ $20.0002, valued at $253.4k
Sold 4,696 shares @ $20, valued at $93.9k
Exercised 12,670 options to buy @ $2.54, valued at $32.2k
Exercised 4,696 options to buy @ $2.54, valued at $11.9k
08/29/2018 4 Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 7,892 shares @ $20, valued at $157.8k
08/22/2018 4 Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 285 shares @ $18.2001, valued at $5.2k
08/02/2018 4 Armour Alison A. (Chief Medical Officer) has filed a Form 4 on ENDOCYTE INC
Txns: Sold 1,414 shares @ $15.9756, valued at $22.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy